Cargando…
Functional DNA Repair Signature of Cancer Cell Lines Exposed to a Set of Cytotoxic Anticancer Drugs Using a Multiplexed Enzymatic Repair Assay on Biochip
The development of resistances to conventional anticancer drugs compromises the efficacy of cancer treatments. In the case of DNA-targeting chemotherapeutic agents, cancer cells may display tolerance to the drug-induced DNA lesions and/or enhanced DNA repair. However, the role of DNA damage response...
Autores principales: | Forestier, Anne, Sarrazy, Fanny, Caillat, Sylvain, Vandenbrouck, Yves, Sauvaigo, Sylvie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534104/ https://www.ncbi.nlm.nih.gov/pubmed/23300565 http://dx.doi.org/10.1371/journal.pone.0051754 |
Ejemplares similares
-
A rapid multiplex cell-free assay on biochip to evaluate functional aspects of double-strand break repair
por: Tatin, Xavier, et al.
Publicado: (2022) -
Alzheimer’s Disease-Associated Neurotoxic Peptide Amyloid-β Impairs Base Excision Repair in Human Neuroblastoma Cells
por: Forestier, Anne, et al.
Publicado: (2012) -
Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips
por: Butvilovskaya, Veronika I., et al.
Publicado: (2016) -
A DNA biochip for on-the-spot multiplexed pathogen identification
por: Yeung, Siu-Wai, et al.
Publicado: (2006) -
Study of interaction of antimutagenic 1,4-dihydropyridine AV-153-Na with DNA-damaging molecules and its impact on DNA repair activity
por: Leonova, Elina, et al.
Publicado: (2018)